American Oriental Bioengineering, Inc.  

(Public, OTCMKTS:AOBI)   Watch this stock  
Find more results for AOBI
0.00 (0.00%)
Feb 17 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 1.05 - 5.40
Open     -
Vol / Avg. 0.00/4.00
Mkt cap 268,555.00
P/E     -
Div/yield     -
EPS -1,227.74
Shares 72,771.00
Beta     -
Inst. own 0%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -118.06% -41.16%
Operating margin -105.78% -33.93%
EBITD margin - -29.60%
Return on average assets -20.07% -11.81%
Return on average equity -29.01% -16.84%
Employees 3,719 -
CDP Score - -


1 Liangshuihe First Avenue Beijing E-Town Ecnmc & Tech Dvlpmnt Area E-Town
+86-10-59822039 (Phone)
+86-10-87857429 (Fax)

External links

Transcripts - SeekingAlpha


American Oriental Bioengineering, Inc. is an integrated pharmaceutical company. The Company is engaged in development, manufacture and commercialization of a broad range of pharmaceutical and healthcare products. The Company’s business consists of prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products. Two flagship prescription pharmaceutical products marketed in China are Shuanghuanglian Lyophilized Injection Powder, or SHL Injection Powder, and Cease Enuresis Soft Gel, or CE Gel. Over-the-counter pharmaceutical products are similar to its prescription pharmaceutical products in that they need approval from the SFDA. Its products in this category include Jinji Series, Cease Enuresis Patch (CE Patch), and Boke Series. Nutraceutical products are intended for the overall well-being. It markets several nutraceutical products in China, which include its soybean peptide based drinks, tablets, powder and instant coffee.

Officers and directors

Shujun Liu Chairman of the Board, Chief Executive Officer
Age: 59
Yanchun Li Chief Financial Officer, Secretary, Director
Age: 43
Xiaopeng Xu Chief Operations Officer
Age: 63
Yan Gao Chief Accounting Officer
Age: 40
Jun Min Vice President, Director
Age: 55
Cosimo J. Patti Independent Director
Age: 62
Xianmin Wang Independent Director
Age: 69
Baiqing Zhang Independent Director
Age: 59